Similarly, CEA levels can be influenced by malignancies such as colorectal cancer, breast cancer, and non-small-cell lung cancer (NSCLC), as well as benign factors like liver and biliary dysfunction (4, 5). The gene discussed is CEACAM5; the disease is breast carcinoma.